Substantivity of Oral Rinses: Comparative Study
SORCOS
Substantivity of Mouthrinse Formulations Containing Cetylpyridinium Chloride and O-cymen-5-Ol Compared to Placebo on Salivary Microbiota
1 other identifier
interventional
16
1 country
1
Brief Summary
A desirable quality of mouthrinses is substantivity an intrinsic feature of some molecules. Substantivity requires the adsorption of the agent on the oral surfaces and subsequently antimicrobial activity bacteriostatic along following hours. This work aims to quantitatively determine the substantivity of (i) a single o-Cymen-5-ol plus CPC oral rinse, (ii) a, CPC oral rinse and (iii) a o-Cymen-5-ol mouthwash on the salivary microbiota up to 4 h after their application.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 3, 2022
CompletedFirst Submitted
Initial submission to the registry
February 23, 2022
CompletedFirst Posted
Study publicly available on registry
May 9, 2022
CompletedMay 11, 2022
May 1, 2022
24 days
February 23, 2022
May 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Preliminary experiments
Measure of surviving bacteria by fluorimetry and confocal microscopy (Live \& dead)
one month
Secondary Outcomes (1)
Substantivity of mouthrinse formulations containing Cetylpyridinium Chloride and O-cymen-5-Ol (single and combined) compared to Placebo on salivary microbiota
up to three months
Study Arms (4)
placebo oral rinse
PLACEBO COMPARATORPlacebo comparator Volume Time Active molecule 15 mL 1 min No
CPC oral rinse
ACTIVE COMPARATORVolume Time Active molecule 15 mL 1 min CPC containing oral rinse
Cymenol oral rinse
ACTIVE COMPARATORVolume Time Active molecule 15 mL 1 min Cymenol containing oral rinse
CPC + Cymenol oral rinse
ACTIVE COMPARATORVolume Time Active molecule 15 mL 1 min CPC+cymenol containing oral rinse
Interventions
Participants use mouthwasher for a given time.
Non-stimulated saliva harvesting
Eligibility Criteria
You may qualify if:
- adult age (\>18 y/o)
- good oral helath status
- minimum 24 evaluable teeth
- periodontal pockets ≤3 mm
- absence of caries \& periodontal haemorrage
You may not qualify if:
- smokers
- prosthesis or orthodontic devices
- Sjögren syndrome
- Antibiotic treatment in the last three months
- Systemic disease with alteration in the production and/or composition of the saliva
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Barcelona. Campus Bellvitge
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
Related Publications (1)
Aguilera FR, Vinas M, Sierra JM, Vinuesa T, R Fernandez de Henestrosa A, Furmanczyk M, Trullas C, Jourdan E, Lopez-Lopez J, Jorba M. Substantivity of mouth-rinse formulations containing cetylpyridinium chloride and O-cymen-5-ol: a randomized-crossover trial. BMC Oral Health. 2022 Dec 27;22(1):646. doi: 10.1186/s12903-022-02688-z.
PMID: 36575444DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Miguel Viñas, PhD
University of Barcelona-Spain-
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full professor Microbiology
Study Record Dates
First Submitted
February 23, 2022
First Posted
May 9, 2022
Study Start
January 1, 2022
Primary Completion
January 25, 2022
Study Completion
February 3, 2022
Last Updated
May 11, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share